Results 21 to 30 of about 172,372 (215)

Metformin for endometrial hyperplasia [PDF]

open access: yesCochrane Database of Systematic Reviews, 2016
Endometrial cancer is one of the most common gynaecological cancers in the world. Rates of endometrial cancer are rising, in part because of rising obesity rates. Endometrial hyperplasia is a precancerous condition in women that can lead to endometrial cancer if left untreated.
Naomi S, Clement   +5 more
openaire   +2 more sources

Atypical endometrial hyperplasia

open access: yes, 2020
Atypical endometrial hyperplasia and cancer at hysterectomy according to endometrial sampling ...
Ciavattini, A
core   +2 more sources

Does Preoperative Diagnosis of Endometrial Hyperplasia Necessitate Intraoperative Frozen Section Consultation?

open access: yesBalkan Medical Journal, 2016
Background: In women with endometrial hyperplasia, there is a risk for co-existent endometrial cancer when patients are subjected to immediate surgical treatment.
Gokhan Boyraz   +4 more
doaj   +1 more source

Diagnostic Value of Moesin and MMP9 Immunohistochemical Expression in Differentiating Endometrial Hyperplasia and Endometrial Carcinoma [PDF]

open access: yesEgyptian Journal of Cancer and Biomedical Research
Background: Endometrial carcinoma is a major health burden, and its development is often preceded by well-defined precursor lesions. Detection of such lesions is particularly significant for early diagnosis and appropriate treatment of endometrial ...
Manar Azzam   +3 more
doaj   +1 more source

Endometrial hyperplasia as a risk factor of endometrial cancer [PDF]

open access: yesArchives of Gynecology and Obstetrics, 2022
AbstractEndometrial hyperplasia (EH) is the precursor lesion for endometrioid adenocarcinoma of the endometrium (EC), which represents the most common malignancy of the female reproductive tract in industrialized countries. The most important risk factor for the development of EH is chronic exposure to unopposed estrogen. Histopathologically, EH can be
Lisa K. Nees   +6 more
openaire   +3 more sources

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia

open access: yesHeliyon, 2022
Endometrial hyperplasia is caused by an excess of estrogen unopposed by progesterone. Oral progestogens are traditionally used for endometrial hyperplasia without atypia.
Ye Shen   +6 more
doaj   +1 more source

Management & prognosis of endometrial hyperplasia [PDF]

open access: yes, 2014
This thesis investigates the management and prognosis of endometrial hyperplasia. The literature on conservative therapies for endometrial hyperplasia is systematically reviewed and a meta-analysis is performed to identify the most effective treatment ...
Gallos, Ioannis D
core   +6 more sources

Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma

open access: yesJournal of Genetic Engineering and Biotechnology, 2021
Background Livin/BIRC7 is a member of the inhibitors of apoptosis proteins family which are implicated in development of cancer through the inhibition of apoptosis process.
Basma K. Elmekkawy   +4 more
doaj   +1 more source

Endometrial Stromal Hyperplasia: An Underrecognized Condition [PDF]

open access: yes, 2013
Hyperplasia of the endometrial stroma is a poorly recognized lesion, lacking widespread recognition with most, if not all, such cases sequestrated in the literature as endometrial stromal nodules or low-grade endometrial stromal sarcomas.
Efthimios Sivridis   +2 more
core   +1 more source

Role of Ki 67 in Normal Endometrium, Endometrial Hyperplasia and Endometrial Carcinoma: A Comparative Study [PDF]

open access: yes, 2023
Introduction: Endometrial carcinoma is the 4th most common malignancy inwomen and its incidence is increasing both in developed and developing countries.
K.T Athulya Krishna Kumar, Krishnaraj Upadhyaya, Ravi Teja Cn
core   +1 more source

Home - About - Disclaimer - Privacy